1. Home
  2. OGI vs CMPX Comparison

OGI vs CMPX Comparison

Compare OGI & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organigram Holdings Inc.

OGI

Organigram Holdings Inc.

HOLD

Current Price

$1.76

Market Cap

218.5M

Sector

Health Care

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.09

Market Cap

752.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGI
CMPX
Founded
2013
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
218.5M
752.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OGI
CMPX
Price
$1.76
$5.09
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$13.44
AVG Volume (30 Days)
1.7M
2.1M
Earning Date
12-16-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$186,075,713.00
N/A
Revenue This Year
$13.11
N/A
Revenue Next Year
$12.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$1.33
52 Week High
$2.24
$5.86

Technical Indicators

Market Signals
Indicator
OGI
CMPX
Relative Strength Index (RSI) 49.82 53.18
Support Level $1.60 $4.83
Resistance Level $2.24 $5.27
Average True Range (ATR) 0.17 0.28
MACD 0.00 -0.06
Stochastic Oscillator 36.00 33.51

Price Performance

Historical Comparison
OGI
CMPX

About OGI Organigram Holdings Inc.

Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: